ABSTRACT tRNAs are highly modified, each with a unique set of modifications. Several reports suggest that tRNAs are hypomodified or, in some cases, hypermodified under different growth conditions and in certain cancers. We previously demonstrated that yeast strains depleted of tRNA His guanylyltransferase accumulate uncharged tRNA His lacking the G −1 residue and subsequently accumulate additional 5-methylcytidine (m 5 C) at residues C 48 and C 50 of tRNA His , due to the activity of the m 5 Cmethyltransferase Trm4. We show here that the increase in tRNA His m 5 C levels does not require loss of Thg1, loss of G −1 of tRNA His , or cell death but is associated with growth arrest following different stress conditions. We find substantially increased tRNA His m 5 C levels after temperature-sensitive strains are grown at nonpermissive temperature, and after wild-type strains are grown to stationary phase, starved for required amino acids, or treated with rapamycin. We observe more modest accumulations of m 5 C in tRNA His after starvation for glucose and after starvation for uracil. In virtually all cases examined, the additional m 5 C on tRNA His occurs while cells are fully viable, and the increase is neither due to the GCN4 pathway, nor to increased Trm4 levels. Moreover, the increased m 5 C appears specific to tRNA His , as tRNA Val(AAC) and tRNA Gly(GCC) have much reduced additional m 5 C during these growth arrest conditions, although they also have C 48 and C 50 and are capable of having increased m 5 C levels. Thus, tRNA His m 5 C levels are unusually responsive to yeast growth conditions, although the significance of this additional m 5 C remains unclear.
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INTRODUCTION
During maturation, tRNA molecules are extensively processed and highly modified with a unique set of post-transcriptional modifications. In Saccharomyces cerevisiae, ∼13 nt are modified in each tRNA, and there are 25 unique tRNA modifications that have been found at 36 positions on the tRNA (Phizicky and Hopper 2010) . These post-transcriptional modifications are highly conserved in different organisms, underscoring their importance. Many tRNA modifications near the anti-codon have important roles in decoding mRNA (Agris et al. 2007) , as evidenced by lethality or slow growth phenotypes (Phizicky and Hopper 2010) . For example, loss of 2 ′ -O-methylation at positions 32 and 34 or loss of either m 1 G or t 6
A at position 37 results in slow growth (Bjork et al. 2001; Pintard et al. 2002; El Yacoubi et al. 2009; Guy et al. 2012) . In addition, a number of modifications in the tRNA body have important roles in stabilizing tRNA (Kadaba et al. 2004; Alexandrov et al. 2006; Kadaba et al. 2006; Chernyakov et al. 2008b; Phizicky and Hopper 2010; Whipple et al. 2011) . However, the precise roles of many modifications are not yet known in detail and are still under investigation.
Although it has been generally assumed that modifications made to tRNAs are constitutively added at similar levels, a number of reports have described altered tRNA modification levels under various conditions in different organisms. Bacillus subtilis tRNAs were reported to be hypomethylated during log phase growth (Singhal and Vold 1976) , and Bacillus stearothermophilus tRNAs have higher 2 ′ -O-methylation levels at 70°C than at 50°C (Agris et al. 1973) . Similarly, several types of cancer cell lines have reduced yW (wybutosine) modification of tRNA Phe (Grunberger et al. 1975; Marini 1979, 1983; Kuchino et al. 1982; Grunberger et al. 1983) , and tRNA Phe species from a hepatoma and a breast carcinoma have an unexpected additional 1-methylguanosine (m 1 G) modification, as well as additional dihydrouridine and 5-methylcytidine (m 5 C) (Kuchino and Borek 1978) . In addition, human and murine hepatoma cells have reduced levels of queosine in their tRNA Asp (Kuchino et al. 1981; Randerath et al. 1984; Pathak et al. 2005) , while in Drosophila, queosine levels of several tRNAs increase with 1 age and with the percentage of yeast in the diet (Hosbach and Kubli 1979; Owenby et al. 1979) .
Emerging data also suggest growth-dependent changes in tRNA modification levels in the yeast Saccharomyces cerevisiae.
Mitochondrial tRNA
Lys(UUU) has reduced 2-thiolation following growth at elevated temperature (Kamenski et al. 2007 ). In addition, it was recently reported that oxidative stress mediated by hydrogen peroxide results in increased levels of m 5 C, 2 ′ -O-methylcytidine (Cm), and 2,2-dimethylguanosine (m 2 2 G) levels and that a number of other modifications are affected by treatment with several chemicals that induce cellular stress (Chan et al. 2010 (Chan et al. , 2012 .
We previously reported that depletion of the essential tRNA His guanylyltransferase Thg1 results in the loss of G −1 from tRNA His , with concomitant accumulation of deacylated tRNA His and the subsequent accumulation of additional m 5 C on tRNA His ∼8 h after the loss of G −1 (Gu et al. 2005 ). The additional m 5 C occurs at residues C 48 and C 50 (∼0.5 mol/ mol tRNA at each position) (Gu et al. 2005) , adjacent to the known m 5 C 49 modification, and appears to be due to Trm4 methyltransferase, which catalyzes formation of m 5 C at C 34 , C 40 , C 48 , and C 49 in all substrate tRNAs in yeast (Motorin and Grosjean 1999) . Interestingly, the additional m 5 C that accumulates following Thg1 depletion was not found on tRNA Gly(GCC) , which also has cytidines at these positions, and tRNA
His was observed to accumulate in the nucleus during Thg1 depletion (Gu et al. 2005) , presumably by retrograde transport of cytoplasmic tRNA to the nucleus (Shaheen and Hopper 2005; Takano et al. 2005) . At the time, we speculated that the additional m 5 C found in tRNA His from Thg1-depleted cells might be due to the increased availability of deacylated tRNA His to Trm4, which is localized to the nucleus (Wu et al. 1998 ), or possibly due to a regulatory response from the uncharged tRNA His as the cells arrested growth due to loss of Thg1 (Gu et al. 2005) . Alternatively, the lack of the G −1 modification on tRNA His might trigger the accumulation of m 5 C, much as Thermus thermophilus cells lacking either m 7 G 46 or ψ 55 have altered modifications under certain conditions (Tomikawa et al. 2010; Ishida et al. 2011) .
In His observed following depletion of Thg1 (Gu et al. 2005) , which adds G −1 to the 5 ′ end of tRNA His (Gu et al. 2003) . The secondary structure and modifications of tRNA His are depicted in Figure 1A . The m 5 C modification (catalyzed by Trm4) is clearly resolved from other nucleosides by reverse-phase HPLC analysis of tRNA His purified from wild-type and trm4-Δ strains (Fig. 1B) . Values of nucleoside modifications are quantified from HPLC traces and are expressed as moles of modification per mole of tRNA (mol/ mol tRNA). C levels is specific to loss of Thg1 function and/or subsequent cell death, we grew a set of temperaturesensitive (ts) strains at permissive or nonpermissive temperatures and analyzed cell viability. We then purified tRNA His and measured modification levels by HPLC analysis. We grew BY4741 (WT) and the thg1-Y146H ts strain as a control for additional m 5 C. We also grew three temperature-sensitive strains unrelated to tRNA processing: the fcp1-1 ts strain, which is defective for transcription by RNA polymerase II at nonpermissive temperature (Kobor et al. 1999) , the abf1-102 ts strain, which has a mutation in a DNA binding protein involved in transcriptional regulation, DNA replication, and DNA repair (Buchman et al. 1988; Reed et al. 1999; Miyake et al. 2004) , and the cdc48-9 ts strain, which has a mutation in an ATPase involved in protein export from the ER to the cytoplasm (Ye et al. 2001) . Growth arrest was apparent by 2-3 h for the fcp1-1 ts strain, by 3-4 h for the thg1-Y146H ts strain, by 6-7 h for the cdc48-9 ts strain, and by over 7 h for the abf1-102 ts strain (data not shown). For two of the temperature-sensitive strains grown at 37°C, we observe an increase in m 5 C levels on tRNA His following growth arrest and without any significant loss of cell viability ( Fig. 2 ; Table 2 ). Thus, at the 7 h time point at 37°C, the fcp1-1 ts and cdc48-9 ts strains are nearly completely viable Expected mol/mol tRNA 3 1 a n = 4, mean ± standard deviation. Expected mol/mol tRNA 3 1 2 1 4 1 1 1 a n = 4, mean ± standard deviation. b n = 2, mean ± standard deviation. c n = 3, mean ± standard deviation. examined modification status of tRNA His in the BY4741 strain after growth into stationary phase and after nutrient starvation.
As BY4741 is grown in SD complete medium, we find that tRNA His m 5 C levels increase from 0.92 mol/mol tRNA in mid-log phase growth to 1.55 mol/mol tRNA in the first day of stationary phase and then gradually increase to 1.81 mol/mol tRNA over the next 5 d of stationary phase (Fig. 3,  black bars) . In contrast, during this time course, the control modifications (Am, Gm+ m 1 G, D, and ψ) remain virtually unchanged in the tRNA His (Fig. 3 , light and dark gray bars; data not shown). The increase in m 5 C seems to correlate with the diauxic shift, which transitions energy production from fermentation to respiration when glucose levels are low (Herman 2002 ). Accumulation of m 5 C is not likely due to cell death since cells in stationary phase are known to be viable (Werner-Washburne et al. 1996; Allen et al. 2006) .
We also find that levels of tRNA His m 5 C increase following several nutrient starvation treatments of the BY4741 strain, in each case with no significant loss of cell viability (Table 3) . We find that m 5 C levels increase significantly following 6 h of starvation for histidine (from 0.86 to 1.80 mol/mol tRNA) and following 24 h of starvation for histidine (to 2.00 mol/mol tRNA), for leucine (to 1.66 mol/mol tRNA), and for a combination of amino acids and uracil (SD minimal; to 1.68 mol/ mol tRNA). m 5 C levels also significantly increase to 1.53 mol/mol tRNA following 24 h of growth in SD complete medium, because the cells had reached saturation. In contrast, we observe a more modest increase in m 5 C levels following 24 h of starvation for glucose (to 1.32 mol/mol tRNA), and a minimal increase following 24 h of starvation for uracil (to 1.23 mol/mol tRNA). The BY4741 strain viable cell titer remained constant during all of these treatments (Table 3) , although cell growth ceased by ∼3 h in each case (data not shown).
It is likely that Trm4 is responsible for the additional m 5 C modifications observed in tRNA His under these conditions, for two reasons. First, Trm4 is the only known S. cerevisiae m 5 C methyltransferase and can catalyze m 5 C formation on substrate tRNAs at C 34 , C 40 , C 48 , and C 49 (Motorin and Grosjean 1999) . Second, trm4-Δ mutants depleted of Thg1 lack all m 5 C, including the additional m 5 C found in tRNA His at C 48 and C 50 (Gu et al. 2005) . Consistent with this, we find that deletion of TRM4 abolishes the accumulation of m 5 C in tRNA His that occurs upon histidine starvation of BY4741 ( C might result from activation of the general amino acid starvation pathway. Indeed, we had previously shown that depletion of Thg1 leads to activation of the GCN4 pathway, in addition to the accumulation of m 5 C on tRNA His (Gu et al. 2005) . Thus, as expected, our amino acid starvation conditions lead to increased levels of both HIS5 and LYS1 mRNAs (Table 3 ; data not shown), which are known to be under GCN4 control (Natarajan et al. 2001) .
Two lines of evidence suggest that the increased m 5 C levels observed in tRNA His during starvation are not due to the GCN4 pathway. First, we find nearly identical levels of elevated m 5 C in tRNA
His after 5 h of histidine starvation of wild-type (0.86 to 1.71 mol/mol tRNA) and gcn4-Δ strains (0.83 to 1.65 mol/mol tRNA) (Table 4) , while control modifications (D, ψ, Gm, m 1 G, and Am) are virtually unchanged (Table 4 ; data not shown). Second, induction of the GCN4 pathway by overexpression of GCN4 from the P GAL promoter, using the yeast movable ORF (MORF) collection (Gelperin et al. 2005) , does not affect m 5 C levels of tRNA His (Table 5) . Accordingly, although overexpression of GCN4-MORF in galactose dramatically increases mRNA levels of the known Gcn4 targets HIS5 and LYS1 relative to levels observed in glucose-containing media, there is only a very limited effect on m 5 C levels of tRNA His (from 0.89 to 0.98 mol/mol tRNA). Similarly, there is no effect on m 5 C levels of tRNA His when the vector control strain is grown in galactose (from 0.87 to 0.89 mol/mol tRNA) or when a control MORF construct (ERV25-MORF) is expressed in galactose (from 0.86 to 0.97 mol/mol tRNA). However, we note that our growth conditions do allow for an increase in tRNA His m 5 C, since overexpression of TRM4-MORF increases tRNA His m 5 C levels to 1.59 mol/ mol tRNA (Table 5) . Thus, we conclude that tRNA His m 5 C levels are not the result of GCN4 pathway induction. His m 5 C levels increase when BY4741 is grown to stationary phase. tRNA His was purified from BY4741 grown in SD complete media in mid-log phase and in stationary phase for the indicated number of days. Nucleoside modifications were analyzed by HPLC, and m 5 C (black), Am (dark gray), and m 1 G + Gm (light gray) values are plotted over time. Other control modifications (dihydrouridine and pseudouridine) were unchanged during the time course (data not shown). The increase in m 5 C levels between log phase growth and Day 1 of stationary phase is highly reproducible (Day 0 log phase, m 5 C = 0.86 ± 0.03, n = 6; Day 1 stationary phase, m 5 C = 1.53 ± 0.11, n = 7, mean ± standard deviation) (see Table 3 ). TORC1 (containing either Tor1 or Tor2), which is inhibited by rapamycin; and TORC2 (containing Tor2), which is insensitive to rapamycin (Loewith et al. 2002) . To inhibit TORC1, we sought to treat cells with rapamycin, but BY4741 is relatively insensitive to rapamycin treatment when TOR1 is present (data not shown). Therefore, we used the W303/CRY1 strain, after first showing that BY4741 and W303/CRY1 had virtually b n = 6, mean ± standard deviation. c n = 5, mean ± standard deviation. d n = 7, mean ± standard deviation. e n = 4, mean ± standard deviation. f n = 3, mean ± standard deviation. ; SD − His 6 h: j P = 6.6 × 10
; 24 h: k P = 7.6 × 10
; SD − Leu 6 h: ; SD − Ura 6 h: n P = 1.4 × 10 (Table 3 ; data not shown). Growth arrest triggered by rapamycin treatment (50, 100, and 150 nM) was apparent by 1.5-2 h, and we observed significant decreases in cell viability after treatment with 100 nM and 150 nM rapamycin for longer than 4.5 h (data not shown). However, we did observe increases in m 5 C levels following several treatments with rapamycin that did not lead to loss of viability. We detected a modest increase in tRNA His m 5 C levels when cells were treated with 150 nM rapamycin for 3 h (from 0.89 ± 0.01 to 1.18 ± 0.03 mol/mol tRNA, mean ± standard deviation; n = 2) (data not shown) and greater increases when cells were treated with 100 nM rapamycin for 4.5 h (from 0.84 to 1.39 mol/mol tRNA) (Table 4) or with 50 nM rapamycin for 24 h (from 0.84 to 1.73 mol/mol tRNA) (data not shown), without loss of viability. In each of these cases, we observe no change in all other tRNA His modifications (Table 4 ; data not shown). These data suggest that inhibition of the TOR pathway or the resulting G1 cell cycle arrest (Kunz et al. 1993; Barbet et al. 1996; Helliwell et al. 1998 ) can trigger additional m 5 C levels on tRNA His . Normalized to HIS5/ACT1 or LYS1/ACT1 values of BG1766 in S − Ura + Glucose media.
Increased m

Trm4 protein levels do not increase during starvation conditions
A simple explanation for the increase in tRNA His m 5 C levels is that Trm4 is more highly expressed during starvation conditions. To monitor endogenous Trm4 levels during starvation, we first inserted a chromosomal affinity tag derived from the MORF library (Gelperin et al. 2005) immediately 5 ′ of the TRM4 stop codon to encode a Trm4-cMORF fusion. We then assayed tRNA His m 5 C levels before and after amino acid starvation, demonstrating that the tag did not alter levels of m 5 C in tRNA His compared to those in a wild-type strain (Table 3) , and using cells from the same growth, we extracted cell lysate and measured Trm4 protein levels by Western blotting for the HA epitope. Control modifications (D, ψ, Gm, m 1 G, and Am) remained constant over the time course of growth (data not shown). However, although tRNA His m 5 C levels are elevated at 24 h in both the wild-type and the TRM4-cMORF strain (Table 3) , we find that Trm4 protein levels appear to decrease at the 24-h time point (Fig. 4) , consistent with experiments that demonstrate reductions in TRM4 mRNA levels (Natarajan et al. 2001 ) and ribosome occupancy (Ingolia et al. 2009 ) following starvation.
Aminoacylation status of tRNA His is variably affected by different starvation conditions
Starvation for a particular amino acid in yeast and in Escherichia coli has been shown to affect the charging status of the corresponding tRNA isoacceptors, with some effects on other tRNAs (Dittmar et al. 2005; Zaborske et al. 2009 ). Therefore, tRNA
His aminoacylation status may be affected by the starvation conditions that we examined, and changes in tRNA His aminoacylation levels might correlate with the amount of additional m 5 C added to tRNA His . To address this possibility, we starved the BY4741 strain for histidine, leucine, uracil, or glucose, or grew BY4741 to stationary phase and extracted RNA in acidic conditions to preserve tRNA aminoacylation. We performed the experiment with two independent cultures which serve as biological replicates. A Northern blot of samples from one of the replicates is shown in Figure 5 . Prior to starvation, when the cultures are growing in log phase (SD complete 0 h), tRNA
His is 66% aminoacylated. Following 24 h of starvation for histidine, leucine, uracil, or glucose, tRNA His is 44%, 60%, 55%, and 52% aminoacylated, respectively. Furthermore, following 24 h of growth in SD complete medium (stationary phase), tRNA His is 66% aminoacylated. These data suggest that aminoacylation levels do not directly correlate with additional m 5 C levels. Although histidine starvation induces the most additional m 5 C and the tRNA His is the most deacylated, we observe no change in aminoacylation levels of tRNA His following entry into stationary phase (Fig. 5) , although tRNA His m 5 C levels increase by 0.67 mol/mol tRNA (Table  3 ). In addition, tRNA
His is more aminoacylated following leucine starvation than following uracil or glucose starvation (Fig. 5) , but leucine starvation induces more additional m 5 C than uracil or glucose (Table 3 ).
Increases in m 5
C levels are unique to tRNA
His
Since additional m 5 C on tRNA His occurs at C 48 and C 50 (adjacent to m 5 C 49 ) in Thg1-depleted cells (Gu et al. 2005) , we examined tRNA Gly(GCC) and tRNA Val(AAC) , two of the four additional tRNAs known to have m 5 C 49 and unmodified C 48 and C 50 (Juhling et al. 2009 ). Consistent with results from Thg1-depleted cells, we find little change in m 5 C levels of these two tRNA species after starvation of wild-type cells (Table 6 ). Whereas histidine starvation for 24 h results in a large increase in tRNA His m 5 C levels (from 0.86 to 2.00 FIGURE 4. Trm4-cMORF levels do not increase during starvation. BY4741 and Trm4-cMORF strains were grown in SD complete, SDHis, or SD -Leu media and grown for 24 h at 30°C. Crude extracts were prepared at 0, 7, and 24 h, and 30 μg of protein were loaded in each lane and resolved by SDS-PAGE, followed by Western blotting. Anti-HA antibody was used to detect the cMORF tag on Trm4. BY4741 crude extract was used as a negative control. The same blot was incubated with anti-enolase antibody as a loading control.
FIGURE 5. Analysis of tRNA His aminoacylation under different starvation conditions. RNA from the wild-type (BY4741) strain grown in the indicated media was isolated in acidic conditions to preserve aminoacylation, and 2 μg of RNA were resolved on an acidic gel, analyzed by Northern blot for tRNA His , tRNA Arg(ICG) , and 5S rRNA, and quantified using ImageQuant software. A control sample was treated with base (+) to detect migration of deacylated tRNA. (Solid arrows) AminoacyltRNA, (dotted arrows) deacyl-tRNA. Each percent aminoacylation value is the mean ± standard deviation (SD) from two independent cultures. A representative Northern blot from one of the two independent cultures is shown. mol/mol tRNA), tRNA Gly(GCC) m 5 C levels increase modestly (from 1.44 to 1.74 mol/mol tRNA), and tRNA Val(AAC) m 5 C levels barely increase (from 0.79 to 1.03 mol/mol tRNA) ( Fig. 6 ; Table 6 ). Similarly, leucine starvation for 24 h results in a substantial increase in tRNA His m 5 C levels (from 0.86 to 1.66 mol/mol tRNA) but only modest increases in m 5 C levels of tRNA Gly(GCC) (from 1.44 to 1.70 mol/mol tRNA) and tRNA Val(AAC) (from 0.79 to 0.98 mol/mol tRNA). Control modification levels for each tRNA remain normal during these treatments (Table 6 ; data not shown). Furthermore, m 5 C levels only slightly increase in tRNA Val(AAC) when temperature-sensitive strains are shifted to 37°C, relative to the drastic induction of additional m 5 C in tRNA His ( Fig. 2B ; Table 2 ). Thus, we infer that m 5 C accumulation occurs preferentially on tRNA His in conditions where cells stop growing. In support of this claim, both tRNA Val(AAC) and tRNA Gly(GCC) have the capacity to acquire additional m 5 C after overexpression of TRM4-MORF (Table 5) . Strikingly, TRM4 overexpression results in a nearly identical increase in m 5 C levels of tRNA His (from 0.86 to 1.59 mol/mol tRNA) and tRNA Val(AAC) (from 0.80 to 1.53 mol/mol tRNA) and a smaller but still significant increase in m 5 C levels of tRNA Gly(GCC) (from 1.56 to 1.98 mol/mol tRNA), whereas all other control modifications (D, ψ, Gm, m 1 G, I, Cm, and Am) are normal (Table 5 ; data not shown). Since both tRNA Val(AAC) and tRNA Gly(GCC) can be modified with additional m 5 C in vivo by Trm4 but are not substrates for additional m 5 C modification (presumably by Trm4) during growth arrest conditions, we conclude that the additional m 5 C during growth arrest is specific to tRNA
His .
DISCUSSION
We have demonstrated here that m (Gu et al. 2005) . We have extended this analysis to show that tRNA His has additional m 5 C when either thg1 temperature-sensitive strains or temperature-sensitive strains unrelated to tRNA function are grown at nonpermissive temperature and when wildtype strains such as BY4741 are grown to saturation or are starved for histidine, amino acids, leucine, or (to a lesser extent) for glucose or uracil. In the majority of these cases, the accumulation of additional m 5 C on tRNA His is not caused by loss of cell viability. In addition, we have shown that the accumulation of additional m 5 C on tRNA His is not due to induction of the GCN4 pathway and is not due to an increase in Trm4 protein levels during our starvation conditions, although the additional m 5 C modification is absent in a trm4-Δ mutant. Remarkably, this additional m 5 C specifically occurs on tRNA His , and not on two other possible substrates, tRNA Val(AAC) or tRNA Gly(GCC) , that also have m (Gu et al. 2005) , and Trm4 is a nuclear protein (Wu et al. 1998) , our data suggest that modulation of tRNA subcellular dynamics is not the sole contributor to additional m 5 C levels, since glucose starvation results in rapid accumulation of tRNAs in the nucleus (Shaheen and Hopper 2005; Whitney et al. 2007 ), but we observe only modest accumulation of m 5 C relative to that observed with histidine or leucine starvation. Three lines of evidence suggest that tRNA charging status is also not the sole contributor to additional m 5 C on tRNA His . First, tRNA His from a thg1-Δ strain has normal m 5 C levels, despite the fact that the tRNA is mostly deacylated (Preston and Phizicky 2010) . Second, tRNA
His has an additional 0.80 mol m 5 C/mol tRNA (Table 3 ) following 24 h of leucine starvation, although tRNA His aminoacylation status is virtually unaffected (Fig. 5) . Third, tRNA
His m 5 C increases by 0.67 mol/mol tRNA (Table 3) when wild-type cells are grown to stationary phase and tRNA His aminoacylation levels are unaltered (Fig. 5 ).
However, it remains possible that both deacylation of tRNA His and its presence in the nucleus contribute to the additional m 5 C that we observe. This would be consistent with the observation that more m 5 C accumulates on tRNA His during histidine starvation than during other starvation conditions. Furthermore, increased m 5 C on tRNA His occurs when tRNAs are known to accumulate in the nucleus: during starvation for amino acids, starvation for glucose, and as cells enter late-log and near-stationary phase (Whitney et al. 2007 ). Indeed, we previously showed that the additional m 5 C that accumulates upon Thg1 depletion occurs at a time when tRNA His is deacylated and is localized to the nucleus (Gu et al. 2005) , and it is known that both charged and uncharged tRNA can accumulate in the nucleus during starvation (Whitney et al. 2007 ). It is not completely clear why different levels of tRNA His m 5 C arise during leucine starvation compared to glucose starvation; however, it is clear that different stress conditions have different effects on the cell since they elicit transcriptionally distinct types of growth arrest (Gasch et al. 2000; Boer et al. 2008; Brauer et al. 2008; Klosinska et al. 2011) .
The specificity of additional m 5 C modification for tRNA , and tRNA Gly(GGC) , the additional m 5 C is much more specific for tRNA
His after temperature shift of fcp1 ts or thg1 ts strains, after starvation of a wild-type strain for histidine or leucine, and after growth to stationary phase. Therefore, we presume that, under these conditions, tRNA
His somehow becomes more accessible to Trm4, or Trm4 activity is altered, but it is not yet clear how this is accomplished. This specificity for tRNA His might possibly be explained by a unique structural property of tRNA His or by a secondary protein that binds tRNA His during growth arrest. One possibility is that specificity is related to the unique sensitivity of histidyl-tRNA His to deacylation in vitro (Chernyakov et al. 2008a; Preston and Phizicky 2010) , and the observation that tRNA His is partially deacylated when isolated (Gu et al. 2005; Preston and Phizicky 2010) , which could mean that this tRNA species is a cellular sensor for poor growth conditions. Although our data demonstrate that the additional m 5 C levels of tRNA His during histidine starvation accumulate independently of the GCN4 gene and are not provoked by induction of the GCN4 pathway, it is not clear if the accumulation of m 5 C of tRNA His involves the TOR pathway, which also plays a role in stationary phase and quiescence (Herman 2002) . We observe a distinct increase in tRNA His m 5 C levels when cells are treated with rapamycin, but this increase is modest compared to other treatments. However, because rapamycin treatment results in G1 phase cell cycle arrest (Kunz et al. 1993; Barbet et al. 1996; Helliwell et al. 1998) , it is difficult to determine whether the increased m 5 C is due to inhibition of the TOR pathway or to the resulting growth arrest. It is intriguing to speculate that the TOR pathway is connected to the accumulation of m 5 C in tRNA His , because high-throughput studies have reported that deletion of TRM4 results in increased rapamycin sensitivity (Parsons et al. 2004 ) and that overexpression of TRM4 confers rapamycin resistance (Butcher et al. 2006) , although we have not been able to observe such effects (data not shown).
The function of the additional m 5 C of tRNA His has not yet been elucidated. Since overexpression of TRM4-MORF appears to increase m 5 C levels of several tRNA species and causes a slow-growth phenotype (Yoshikawa et al. 2011 ; data not shown; JM Dewe and EM Phizicky, unpubl.), we infer that excess m 5 C modification has a deleterious effect on function of one or more tRNAs. Conversely, m 5 C modification of tRNAs can play a protective role during stress conditions. Amino acid starvation in Tetrahymena and oxidative stress in yeast, humans, and plants results in cleavage of tRNAs in the anti-codon loop (Lee and Collins 2005; Thompson et al. 2008) , and the Drosophila m 5 C methyltransferase Dnmt2 is important for viability during oxidative stress and heat shock conditions (Schaefer et al. 2010) , because its modification of C 38 in the anti-codon loop protects substrate tRNAs from cleavage by angiogenin in both Drosophila and mice (Goll et al. 2006; Schaefer et al. 2010 (Alexandrov et al. 2006; Chernyakov et al. 2008b; Dewe et al. 2012) . Intriguingly, while preparing this manuscript, it was reported that hydrogen peroxide treatment leads to alteration of m 5 C levels in yeast tRNA Leu(CAA) , with 70% more m 5 C 34 and 20% less m 5 C 48 , and these changes were associated with increased expression of a ribosomal protein enriched with TTG codons (Chan et al. 2012) . Further experiments will be required to fully understand the biology of m 
MATERIALS AND METHODS
Strain construction
Strains used in this study are listed in Table 7 .
To construct the gcn4-Δ::ble R (MBY934) strain, we amplified the phleomycin resistance cassette from the pUG66 plasmid (Gueldener et al. 2002) ′ ). This extended PCR product was transformed into BY4741 as previously described (Sherman 1991) and selected on YPD media containing 8 μg/mL phleomycin (Chernyakov et al. 2008b ). The gcn4-Δ::ble R strain was verified by PCR. The TRM4-cMORF strain, MBY1026B, was constructed in a manner similar to the gcn4-Δ::ble R strain. We used the plasmid, AVA0258, which encodes the cMORF tag (consisting of His6, HA epitope, 3C protease site, ZZ protein A), followed by Kluyveromyces lactis URA3 as a marker for insertion into the chromosome. We PCR-amplified this construct using TRM4 C-ter + TAP 5 ′ (5 ′ -GAACCTCTA CTGAAGCTCCTAGCGCTGCTAATAACCCAGCTTTCTTGTA CAAAGTGG-3 ′ ; contains 43 nt corresponding to the C terminus of Trm4 without the stop codon and a 5 ′ portion of the cMORF tag sequence), and TRM4 Downstream (w/stop) + TAP 3 ′ (5 ′ -CTTT ACAGTGGAGGGGATAAGAAACATGATAACTATCATACGACT CACTATAGGG-3 ′ ; inserts the Trm4 stop codon after the cMORF tag and URA3 marker and contains 43 nt of the region downstream from TRM4). We then used this PCR product to extend the regions homologous to TRM4 by PCR amplification with TRM4 C-ter extended (TAP) 5 ′ (5 ′ -GACTGAATCTCCCGCAGAAACTACTA CCGGAACCTCTACTGAAGCTC-3 ′ ) and TRM4 Downstream extended (TAP) 3 ′ (5 ′ -AGTATTATATTCTTATTTTTGCCTTTTAA TAATATACATTTACTTTACAGTGGAGGGGAT-3 ′ ). The resulting strain was verified by PCR.
We constructed thg1 temperature-sensitive (thg1 ts ) strains, MBY294 (thg1-Y8C), MBY289 (thg1-G172D,L233S), and MBY303 (thg1-Y146H) in two steps. First, we randomly mutagenized a single copy THG1 plasmid, screened for temperature sensitivity in a thg1-Δ strain, and sequenced the resulting alleles. We then inserted these thg1 ts alleles and wild-type THG1 into the THG1 locus by transformation of the SC1300-2 strain in which THG1 was deleted with a LEU2,CYH2 cassette in a cyh r background, and selected for cycloheximide resistance, accompanied by leucine auxotrophy. Temperature sensitivity was confirmed and complemented by a wild-type copy of THG1.
Strain starvation
Strains were grown to log phase at 30°C in SD complete media, then spun down and resuspended in the following media conditions: SD complete, SD minimal (contains only yeast nitrogen base and glucose), SD − His, SD − Leu, SD − Ura, or S complete no glucose. These cultures were grown for 24 h at 30°C, and cells were harvested for analysis of tRNA modifications at indicated times.
Temperature-sensitive strain growth
Strains were grown to log phase in YPD at 24°C, diluted to OD 600 = 0.5 and grown at either 24°C or 37°C for the time indicated.
Rapamycin treatment of W303/CRY1
W303 was pretreated with DMSO by growing in YPD media containing 1% DMSO overnight until the strain reached early log phase. Cells were harvested prior to drug treatment and after growth in the MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Open Biosystems W303/CRY1 MAT α ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-1 D. Krysan SC1300-2 MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cyh r
BY4741
This study thg1-Δ0::LEU2,CYH2 [CEN URA3 P GAL THG1] MBY289
MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cyh r thg1-G172D/L233S SC1300-2 This study MBY294
MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cyh r thg1-Y8C SC1300-2 This study MBY303
MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cyh r thg1-Y146H SC1300-2 This study MBY308
MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cyh r THG1 SC1300-2 This study MBY480
MAT a thg1-Δ0:kanMX BY4741 (Preston and Phizicky 2010) [2μ LEU2 tRNA His A 73 , 2μ HIS3 P HTS1 -HTS1] Y08328
MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 abf1-102 BY4741 C. Boone Y09266
MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fcp1-1 BY4741 C. Boone MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cdc48-9(Y-F) BY4741 C. Boone MBY934A,B MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 gcn4-Δ::ble R
This study MBY1026B
MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 TRM4-cMORF(His 6 -HA epitope-3C site-ZZ protein A)-K. lactis URA3
This study
MBY687A
MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 trm4-Δ::kanMX BY4741 This study
